High intensity focused ultrasound for the treatment of solid tumors: a pilot study in canine cancer patients
dc.contributor.author | Carroll, Jennifer | en |
dc.contributor.author | Coutermarsh-Ott, Sheryl | en |
dc.contributor.author | Klahn, Shawna L. | en |
dc.contributor.author | Tuohy, Joanne L. | en |
dc.contributor.author | Barry, Sabrina L. | en |
dc.contributor.author | Allen, Irving C. | en |
dc.contributor.author | Hay, Alayna N. | en |
dc.contributor.author | Ruth, Jeffrey | en |
dc.contributor.author | Dervisis, Nikolaos G. | en |
dc.date.accessioned | 2022-08-02T19:53:53Z | en |
dc.date.available | 2022-08-02T19:53:53Z | en |
dc.date.issued | 2022-01 | en |
dc.date.updated | 2022-08-02T19:11:08Z | en |
dc.description.abstract | Purpose: To investigate the safety, feasibility, and outcomes of High-Intensity Focused Ultrasound (HIFU) for the treatment of solid tumors in a spontaneous canine cancer model. Methods: Dogs diagnosed with subcutaneous solid tumors were recruited, staged and pretreatment biopsies were obtained. A single HIFU treatment was delivered to result in partial tumor ablation using a commercially available HIFU unit. Tumors were resected 3-6 days post HIFU and samples obtained for histopathology and immunohistochemistry. Total RNA was isolated from paired pre and post treated FFPE tumor samples, and quantitative gene expression analysis was performed using the nCounter Canine IO Panel. Results: A total of 20 dogs diagnosed with solid tumors were recruited and treated in the study. Tumors treated included Soft Tissue Sarcoma (<i>n</i> = 15), Mast Cell Tumor (<i>n</i> = 3), Osteosarcoma (<i>n</i> = 1), and Thyroid Carcinoma (<i>n</i> = 1). HIFU was well tolerated with only 1 dog experiencing a clinically significant adverse event. Pathology confirmed the presence of complete tissue ablation at the HIFU targeted site and immunohistochemistry indicated immune cell infiltration at the treated/untreated tumor border. Quantitative gene expression analysis indicated that 28 genes associated with T-cell activation were differentially expressed post-HIFU. Conclusions: HIFU appears to be safe and feasible for the treatment of subcutaneous canine solid tumors, resulting in ablation of the targeted tissue. HIFU induced immunostimulatory changes, highlighting the canine cancer patient as an attractive model for studying the effects of focal ablation therapies on the tumor microenvironment. | en |
dc.description.version | Published version | en |
dc.format.extent | Pages 855-864 | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.doi | https://doi.org/10.1080/02656736.2022.2097323 | en |
dc.identifier.eissn | 1464-5157 | en |
dc.identifier.issn | 0265-6736 | en |
dc.identifier.issue | 1 | en |
dc.identifier.orcid | Dervisis, Nikolaos [0000-0003-2869-1483] | en |
dc.identifier.pmid | 35848421 | en |
dc.identifier.uri | http://hdl.handle.net/10919/111429 | en |
dc.identifier.volume | 39 | en |
dc.language.iso | en | en |
dc.publisher | Taylor & Francis | en |
dc.relation.uri | https://www.ncbi.nlm.nih.gov/pubmed/35848421 | en |
dc.rights | Creative Commons Attribution 4.0 International | en |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | Dog | en |
dc.subject | High-intensity focused ultrasound | en |
dc.subject | immunotherapy | en |
dc.subject | thermal ablation | en |
dc.subject | Rare Diseases | en |
dc.subject | Cancer | en |
dc.subject.mesh | Animals | en |
dc.subject.mesh | Dogs | en |
dc.subject.mesh | Sarcoma | en |
dc.subject.mesh | Pilot Projects | en |
dc.subject.mesh | High-Intensity Focused Ultrasound Ablation | en |
dc.subject.mesh | Tumor Microenvironment | en |
dc.title | High intensity focused ultrasound for the treatment of solid tumors: a pilot study in canine cancer patients | en |
dc.title.serial | International Journal of Hyperthermia | en |
dc.type | Article - Refereed | en |
dc.type.dcmitype | Text | en |
dc.type.other | Journal Article | en |
pubs.organisational-group | /Virginia Tech | en |
pubs.organisational-group | /Virginia Tech/Veterinary Medicine | en |
pubs.organisational-group | /Virginia Tech/Veterinary Medicine/Small Animal Clinical Sciences | en |
pubs.organisational-group | /Virginia Tech/University Research Institutes | en |
pubs.organisational-group | /Virginia Tech/University Research Institutes/Fralin Life Sciences | en |
pubs.organisational-group | /Virginia Tech/Faculty of Health Sciences | en |
pubs.organisational-group | /Virginia Tech/All T&R Faculty | en |
pubs.organisational-group | /Virginia Tech/Veterinary Medicine/CVM T&R Faculty | en |
pubs.organisational-group | /Virginia Tech/University Research Institutes/Fralin Life Sciences/Durelle Scott | en |
pubs.organisational-group | /Virginia Tech/VT Carilion School of Medicine | en |
pubs.organisational-group | /Virginia Tech/VT Carilion School of Medicine/Internal Medicine | en |
pubs.organisational-group | /Virginia Tech/VT Carilion School of Medicine/Internal Medicine/Secondary Appointment-Internal Medicine | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- CarrollHigh2022.pdf
- Size:
- 2.9 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published version
Collections
All Faculty Deposits
Open Access Subvention Fund Articles
Scholarly Works, Biomedical Sciences and Pathobiology
Scholarly Works, Institute for Critical Technology and Applied Science (ICTAS)
Scholarly Works, Small Animal Clinical Sciences
Scholarly Works, Virginia Tech Carilion School of Medicine (VTCSOM)
Open Access Subvention Fund Articles
Scholarly Works, Biomedical Sciences and Pathobiology
Scholarly Works, Institute for Critical Technology and Applied Science (ICTAS)
Scholarly Works, Small Animal Clinical Sciences
Scholarly Works, Virginia Tech Carilion School of Medicine (VTCSOM)